ArticlePloS one2025
Predictive value of aorta enhancement on computed tomographic pulmonary angiography in pulmonary embolism.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary embolism (PE) is a life-threatening condition requiring prompt diagnosis and treatment. Visual assessment of computed tomographic pulmonary angiography (CTPA) is the first-choice diagnostic tool. New imaging biomarkers could provide additional prognostic information for improved risk stratification. We hypothesized in this exploratory study, that contrast enhancement patterns in the aorta may contain such information.
methodsCTPA scans of 93 acute PE patients were analyzed retrospectively. Firstly, the aorta was segmented automatically by TotalSegmentator and its centerline was extracted. Subsequently, lines were fitted on intensities within a region of interest perpendicularly to the aorta centerline, from which three parameters were extracted: mean intensity, proximal intensity and contrast gradient. After confounder analysis, logistic regression with forward selection evaluated the predictive value of these parameters for 12 adverse outcomes (six short-term and six long-term).
resultsLung volume, aorta dimension and contrast delay were considered as possible confounders but were not selected by forward selection. Logistic regression (n = 93) showed that a less steep contrast gradient (decreasing by 10 Hounsfield unit/%) was associated with a reduction in odds of the following short-term adverse outcomes: 48.1% for intensive care unit admission (odds ratio [OR] = 0.519, 95% confidence interval [CI]: 0.306-0.804), 29.3% for oxygen therapy >24 hours (OR = 0.707, 95% CI: 0.496-0.976), 60.6% for reperfusion therapy (OR = 0.394, 95% CI: 0.178-0.682), 57.5% for vasopressor therapy (OR = 0.425, 95% CI: 0.194-0.741), and 50.2% for PE-related death (OR = 0.498, 95% CI: 0.246-0.915). No significant associations were found with long-term outcomes.
conclusionsThe aorta contrast gradient, automatically quantified from CTPA, is a relevant adjunctive predictor for short-term outcomes in PE patients. Long-term outcomes, however, could not be predicted by aorta measurement. This pilot study provides initial insights into predictive value of aorta enhancement, stimulating further exploration with external data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.